Bi-directionality of Brain–Gut Interactions in Patients With Inflammatory Bowel Disease David J. Gracie, Elspeth A. Guthrie, P. John Hamlin, Alexander C. Ford Gastroenterology Volume 154, Issue 6, Pages 1635-1646.e3 (May 2018) DOI: 10.1053/j.gastro.2018.01.027 Copyright © 2018 AGA Institute Terms and Conditions
Gastroenterology 2018 154, 1635-1646. e3DOI: (10. 1053/j. gastro. 2018 Copyright © 2018 AGA Institute Terms and Conditions
Figure 1 Survival analysis for new-onset abnormal anxiety scores between patients with quiescent and active disease at baseline. Gastroenterology 2018 154, 1635-1646.e3DOI: (10.1053/j.gastro.2018.01.027) Copyright © 2018 AGA Institute Terms and Conditions
Figure 2 Survival analysis for glucocorticosteroid prescription or flare of disease activity between patients with and without abnormal anxiety scores at baseline. Gastroenterology 2018 154, 1635-1646.e3DOI: (10.1053/j.gastro.2018.01.027) Copyright © 2018 AGA Institute Terms and Conditions
Figure 3 Survival analysis for escalation of medical therapy in response to uncontrolled IBD between patients with and without abnormal anxiety scores at baseline. Gastroenterology 2018 154, 1635-1646.e3DOI: (10.1053/j.gastro.2018.01.027) Copyright © 2018 AGA Institute Terms and Conditions
Supplementary Figure 1 Participant retention throughout longitudinal follow-up. Gastroenterology 2018 154, 1635-1646.e3DOI: (10.1053/j.gastro.2018.01.027) Copyright © 2018 AGA Institute Terms and Conditions